370 related articles for article (PubMed ID: 22240409)
1. Clinical features of paediatric pulmonary hypertension: a registry study.
Berger RM; Beghetti M; Humpl T; Raskob GE; Ivy DD; Jing ZC; Bonnet D; Schulze-Neick I; Barst RJ
Lancet; 2012 Feb; 379(9815):537-46. PubMed ID: 22240409
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).
Beghetti M; Schulze-Neick I; Berger RM; Ivy DD; Bonnet D; Weintraub RG; Saji T; Yung D; Mallory GB; Geiger R; Berger JT; Barst RJ; Humpl T;
Int J Cardiol; 2016 Jan; 203():325-30. PubMed ID: 26583838
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
Ploegstra MJ; Ivy DD; Beghetti M; Bonnet D; Alehan D; Ablonczy L; Mattos S; Bowers D; Humpl T; Berger RMF;
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):66-76. PubMed ID: 36972621
[TBL] [Abstract][Full Text] [Related]
4. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
6. Growth in children with pulmonary arterial hypertension: a longitudinal retrospective multiregistry study.
Ploegstra MJ; Ivy DD; Wheeler JG; Brand M; Beghetti M; Rosenzweig EB; Humpl T; Iriart X; Rouzic EM; Bonnet D; Berger RM
Lancet Respir Med; 2016 Apr; 4(4):281-90. PubMed ID: 26994897
[TBL] [Abstract][Full Text] [Related]
7. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.
Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD
Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension].
Zhang G; Shang X; Deng X; Zhou H
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1001-5. PubMed ID: 25623345
[TBL] [Abstract][Full Text] [Related]
10. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
[TBL] [Abstract][Full Text] [Related]
11. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
[TBL] [Abstract][Full Text] [Related]
13. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
Zhang C; Li Q; Liu T; Gu H
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
[TBL] [Abstract][Full Text] [Related]
15. Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry.
Humpl T; Berger RMF; Austin ED; Fasnacht Boillat MS; Bonnet D; Ivy DD; Zuk M; Beghetti M; Schulze-Neick I
Cardiol Young; 2017 Aug; 27(6):1123-1132. PubMed ID: 27995825
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
17. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
[TBL] [Abstract][Full Text] [Related]
18. RV stroke work in children with pulmonary arterial hypertension: estimation based on invasive haemodynamic assessment and correlation with outcomes.
Di Maria MV; Younoszai AK; Mertens L; Landeck BF; Ivy DD; Hunter KS; Friedberg MK
Heart; 2014 Sep; 100(17):1342-7. PubMed ID: 24780910
[TBL] [Abstract][Full Text] [Related]
19. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
